Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas
| hal.structure.identifier | Mathematical Oncology Laboratory [Ciudad Real] [MôLAB] | |
| dc.contributor.author | HENARES-MOLINA, Araceli | |
| hal.structure.identifier | Institut de Mathématiques de Bordeaux [IMB] | |
| hal.structure.identifier | Modélisation Mathématique pour l'Oncologie [MONC] | |
| dc.contributor.author | BENZEKRY, Sébastien | |
| hal.structure.identifier | Department of Radiation Oncology [Las Palmas de Gran Canaria] | |
| dc.contributor.author | LARA, Pedro | |
| hal.structure.identifier | Department of Pathology [Jerez de la Frontera] | |
| dc.contributor.author | GARCÍA-ROJO, Marcial | |
| hal.structure.identifier | Mathematical Oncology Laboratory [Ciudad Real] [MôLAB] | |
| dc.contributor.author | PÉREZ-GARCÍA, Víctor | |
| hal.structure.identifier | Mathematical Oncology Laboratory [Ciudad Real] [MôLAB] | |
| dc.contributor.author | MARTÍNEZ-GONZÁLEZ, Alicia | |
| dc.date.issued | 2017 | |
| dc.identifier.issn | 1932-6203 | |
| dc.description.abstractEn | Grade II gliomas are slowly growing primary brain tumors that affect mostly young patients. Cytotoxic therapies (radiotherapy and/or chemotherapy) are used initially only for patients having a bad prognosis. These therapies are planned following the " maximum dose in minimum time " principle, i. e. the same schedule used for high-grade brain tumors in spite of their very different behavior. These tumors transform after a variable time into high-grade gliomas, which significantly decreases the patient's life expectancy. In this paper we study mathematical models describing the growth of grade II gliomas in response to radiotherapy. We find that protracted metronomic fractionations, i.e. therapeutical schedules enlarging the time interval between low-dose radiotherapy fractions, may lead to a better tumor control without an increase in toxicity. Other non-standard fractionations such as protracted or hypoprotracted schemes may also be beneficial. The potential survival improvement depends on the tumor's proliferation rate and can be even of the order of years. A conservative metronomic scheme, still being a suboptimal treatment, delays the time to malignant progression by at least one year when compared to the standard scheme. | |
| dc.language.iso | en | |
| dc.publisher | Public Library of Science | |
| dc.title.en | Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas | |
| dc.type | Article de revue | |
| dc.identifier.doi | 10.1371/journal.pone.0178552.t001 | |
| dc.subject.hal | Sciences du Vivant [q-bio]/Cancer | |
| bordeaux.journal | PLoS ONE | |
| bordeaux.peerReviewed | oui | |
| hal.identifier | hal-01532505 | |
| hal.version | 1 | |
| hal.popular | non | |
| hal.audience | Internationale | |
| hal.origin.link | https://hal.archives-ouvertes.fr//hal-01532505v1 | |
| bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=PLoS%20ONE&rft.date=2017&rft.eissn=1932-6203&rft.issn=1932-6203&rft.au=HENARES-MOLINA,%20Araceli&BENZEKRY,%20S%C3%A9bastien&LARA,%20Pedro&GARC%C3%8DA-ROJO,%20Marcial&P%C3%89REZ-GARC%C3%8DA,%20V%C3%ADctor&rft.genre=article |
Fichier(s) constituant ce document
| Fichiers | Taille | Format | Vue |
|---|---|---|---|
|
Il n'y a pas de fichiers associés à ce document. |
|||